{"id":568681,"date":"2020-01-30T04:22:53","date_gmt":"2020-01-30T04:22:53","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/"},"modified":"2020-01-30T04:22:53","modified_gmt":"2020-01-30T04:22:53","slug":"acdima-pharma-chairman-steps-down-citing-differences-with-shareholders","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/","title":{"rendered":"ACDIMA Pharma Chairman steps down citing differences with shareholders"},"content":{"rendered":"<p><strong>MOVES- Chairm<\/strong><strong>an Ahmed Hegazy has resigned from his position as chairman of <\/strong><strong>October Pharma<\/strong>, <a href=\"http:\/\/bit.ly\/311KXLj\">sources close to the company told Al Mal<\/a>. Hegazy is also the chairman of <strong><a href=\"http:\/\/acdima-egypt.com\/\">ACDIMA Pharma<\/a><\/strong>, which owns a 30% stake in October. ACDIMA shareholders reportedly raised conflict of interest concerns arising from Hegazy simultaneously holding both positions. ACDIMA had initially nominated him to represent the company on the board, but appears to have changed its stance. In response to the shareholders\u2019 concerns, <a href=\"https:\/\/enterprise.press\/stories\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute-8549\/\">the General Authority for Freezones and Investment restricted Hegazy<\/a> from becoming a member on the board of any other companies, prompting him to step down from his position. October Pharma has not yet chosen who will replace the former chairman.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MOVES- Chairman Ahmed Hegazy has resigned from his position as chairman of October Pharma, sources close to the company told Al Mal. Hegazy is also the chairman of ACDIMA Pharma, which owns a 30% stake in October. ACDIMA shareholders reportedly raised conflict of interest concerns arising from Hegazy simultaneously holding both positions. ACDIMA had initially [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[3706,957,72,4492,427,4490,2380,4491],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-568681","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-acdima","tag-dispute-watch","tag-enterpriseam","tag-general-investment-authority","tag-pharma","tag-resigns","tag-speed-round","tag-steps-down","wpautop","entry"],"acf":{"mongo_id":"75ef82d7-476b-48cc-b1bb-92608158f2fc","is_powered_by":true,"section_story_id":"ec10025b-169b-47c4-a0b7-a14f8b6618ee","story_type":"1","photo_url":"","photo_position":"above","related_issue":[568659],"teaser":"","voice_url":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ACDIMA Pharma Chairman steps down citing differences with shareholders - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ACDIMA Pharma Chairman steps down citing differences with shareholders\" \/>\n<meta property=\"og:description\" content=\"MOVES- Chairman Ahmed Hegazy has resigned from his position as chairman of October Pharma, sources close to the company told Al Mal. Hegazy is also the chairman of ACDIMA Pharma, which owns a 30% stake in October. ACDIMA shareholders reportedly raised conflict of interest concerns arising from Hegazy simultaneously holding both positions. ACDIMA had initially [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-30T04:22:53+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"ACDIMA Pharma Chairman steps down citing differences with shareholders\",\"datePublished\":\"2020-01-30T04:22:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/\"},\"wordCount\":126,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"ACDIMA\",\"dispute watch\",\"EnterpriseAM\",\"general investment authority\",\"pharma\",\"resigns\",\"SPEED ROUND\",\"steps down\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/\",\"name\":\"ACDIMA Pharma Chairman steps down citing differences with shareholders - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2020-01-30T04:22:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ACDIMA Pharma Chairman steps down citing differences with shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ACDIMA Pharma Chairman steps down citing differences with shareholders - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/","og_locale":"en_US","og_type":"article","og_title":"ACDIMA Pharma Chairman steps down citing differences with shareholders","og_description":"MOVES- Chairman Ahmed Hegazy has resigned from his position as chairman of October Pharma, sources close to the company told Al Mal. Hegazy is also the chairman of ACDIMA Pharma, which owns a 30% stake in October. ACDIMA shareholders reportedly raised conflict of interest concerns arising from Hegazy simultaneously holding both positions. ACDIMA had initially [&hellip;]","og_url":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2020-01-30T04:22:53+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"ACDIMA Pharma Chairman steps down citing differences with shareholders","datePublished":"2020-01-30T04:22:53+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/"},"wordCount":126,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["ACDIMA","dispute watch","EnterpriseAM","general investment authority","pharma","resigns","SPEED ROUND","steps down"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/","url":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/","name":"ACDIMA Pharma Chairman steps down citing differences with shareholders - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2020-01-30T04:22:53+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2020\/01\/30\/acdima-pharma-chairman-steps-down-citing-differences-with-shareholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"ACDIMA Pharma Chairman steps down citing differences with shareholders"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":591787,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/17\/gafi-intervenes-in-october-pharma-shareholder-dispute\/","url_meta":{"origin":568681,"position":0},"title":"GAFI intervenes in October Pharma shareholder dispute","author":"enterpriseam admin","date":"17 December 2019","format":false,"excerpt":"DISPUTE WATCH- GAFI intervenes in OctoberPharma shareholder dispute: The General Authority for Freezones and Investment (GAFI) has prohibited HoldiPharma Chairman Ahmed Hegazy from serving on the board of OctoberPharma due to a potential conflict of interest, according to a GAFI letter obtained by Al Mal. Acdima, which owns a 30%\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":565019,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-is-staying-put-for-now\/","url_meta":{"origin":568681,"position":1},"title":"GSK is staying put \u2014 for now","author":"enterpriseam admin","date":"14 March 2021","format":false,"excerpt":"GSK puts Egypt exit on the backburner: GlaxoSmithKline has shelved plans to sell its units in Egypt and Tunisia following the breakdown of talks with UK-listed Hikma Pharma, the company said in a disclosure (pdf) to the EGX today. The pharma giant initially wanted to sell its entire 91.2% stake\u2026","rel":"","context":"In &quot;SPEED ROUND: M&amp;A WATCH&quot;","block_context":{"text":"SPEED ROUND: M&amp;A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round-ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":647688,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/17\/acdima-lincoln-compass-capital-eyeing-united-pharma-iv-solutions-acquisition\/","url_meta":{"origin":568681,"position":2},"title":"ACDIMA, Lincoln, Compass Capital eyeing United Pharma IV Solutions acquisition","author":"enterpriseam admin","date":"17 May 2017","format":false,"excerpt":"M&A WATCH- US investment fund Lincoln Investment, ACDIMA, and a Compass Capital fund are going head-to-head in a race to acquire United Pharma IV Solutions, Al Mal reports. Al Mal says Lincoln\u2019s bid is in the EGP 450-540 mn range, while Compass Capital has offered EGP 450-500 mn, but negotiations\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":634859,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/01\/28\/united-pharma-iv-acdima-merger-falls-apart\/","url_meta":{"origin":568681,"position":3},"title":"United Pharma IV, ACDIMA merger falls apart","author":"enterpriseam admin","date":"28 January 2018","format":false,"excerpt":"M&A WATCH- United Pharma IV, ACDIMA merger falls apart: United Pharma IV rejected ACDIMA\u2019s offer to acquire it for EGP 320 mn, United Pharma IV Chairman Abdullah Mahfouz tells Al Borsa. Mahfouz added that his company, which he believes is valued at EGP 600 mn, ended talks after ACDIMA held\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":630294,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/04\/17\/acdima-to-invest-egp-627-mn-in-new-pharma-projects\/","url_meta":{"origin":568681,"position":4},"title":"ACDIMA to invest EGP 627 mn in new pharma projects","author":"enterpriseam admin","date":"17 April 2018","format":false,"excerpt":"INVESTMENT WATCH- The Arab Company for Drug Industries and Medical Appliance\u2019s (ACDIMA) is planning to invest EGP 627 mn in growth, according to Health Minister Ahmed Rady. The majority of the investments will be used to acquire private pharmaceutical company T3A. State-Owned ACDIMA had in November signed off on new\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":649357,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/04\/30\/acdima-in-talks-to-acquire-united-pharma-iv-solutions\/","url_meta":{"origin":568681,"position":5},"title":"ACDIMA in talks to acquire United Pharma IV Solutions","author":"enterpriseam admin","date":"30 April 2017","format":false,"excerpt":"The Arab Company for Drugs Industries & Medical Appliances (ACDIMA) is in talks to acquire United Pharma IV Solutions, Health Minister Ahmed Rady said, Al Borsa reports. According to chairman Abdallah Mahfouz, United Pharma has postponed deciding on three acquisition offers it previously received in anticipation of possibly reopening its\u2026","rel":"","context":"In &quot;Health + Education&quot;","block_context":{"text":"Health + Education","link":"https:\/\/enterpriseam.com\/egypt\/category\/health-education\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/568681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=568681"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/568681\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/568659"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=568681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=568681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=568681"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=568681"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=568681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}